Ex vivo oxidatively stressed CLL cells in chronic lymphocytic leukemia (CLL) treatment

摘要

The use in the preparation of a medicament for administration to a patient to alleviate symptoms of chronic lymphocytic leukemia, of compatible, oxidatively stressed malignant chronic lymphocytic leukemia (CLL) cells which have been obtained from the patient, from a compatible mammalism donor or from cultured cell lines and extracorporeally subjected to an oxidizing agent and UV radiation.